Odile Goria

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Christophe Corpechot, Olivier Chazouillères, Alexandra Rousseau et al. · New England Journal of Medicine · 2018 · 611 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)

Jean–Claude Trinchet, Valérie Bourcier, Cendrine Chaffaut et al. · Hepatology · 2015 · 134 citations

Medicine, Infectious Diseases, Internal Medicine +17

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy

Dominique Thabut, Christophe Bureau, Richard Layese et al. · Gastroenterology · 2019 · 131 citations · Full text

Medicine, Internal Medicine, Disease Surveillance +16

Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis

Nathalie Ganne‐Carrié, Cendrine Chaffaut, Valérie Bourcier et al. · Journal of Hepatology · 2018 · 124 citations · Full text

Medicine, Oncology, Pathology +14